NeuroSense Sets Nasdaq Hearing as Listing Deficiency Remains
Shares remain listed while NeuroSense seeks to address a market-value requirement and prepares regulatory and funding milestones for PrimeC.
Makkler Newsroom · Oct 13, 03:47 PM · 1 min read
